1. Intestinal HAdV Infection: Tissue Specificity, Persistence, and Implications for Antiviral Therapy
   Karin Kosulin, 2019, Viruses CrossRef
2. Identification of novel human adenovirus candidates using the coxsackievirus and adenovirus receptor for cell entry
   Kemal Mese et al, 2020, Virology Journal CrossRef
3. Engineering Oncolytic Adenoviruses with VSVG‐Decorated Tumor Cell Membranes for Synergistically Enhanced Antitumor Therapy
   Li‐Li Huang et al, 2023, Advanced Functional Materials CrossRef
4. Polymeric delivery systems for nucleic acid therapeutics: Approaching the clinic
   Annette I.S. van den Berg et al, 2021, Journal of Controlled Release CrossRef
5. Polymeric Systems for Cancer Immunotherapy: A Review
   Thai Minh Duy Le et al, 2022, Frontiers in Immunology CrossRef
6. SELDI-TOF MS Analysis of Hepatocellular Carcinoma in an Australian Cohort
   Steven M. Schlichtemeier et al, 2019, Journal of Surgical Research CrossRef
7. Adenovirus Receptor Expression in Cancer and Its Multifaceted Role in Oncolytic Adenovirus Therapy
   Lobke C.M. Hensen et al, 2020, International Journal of Molecular Sciences CrossRef
8. Overcoming the limitations of locally administered oncolytic virotherapy
   JinWoo Hong et al, 2019, BMC Biomedical Engineering CrossRef
9. Nanomedicine for advanced cancer immunotherapy
   Yen N. Diep et al, 2022, Journal of Controlled Release CrossRef
10. Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35
    Ryosuke Ono et al, 2021, Molecular Therapy - Oncolytics CrossRef
11. Overcoming the barriers to optimization of adenovirus delivery using biomaterials: Current status and future perspective
    Dayananda Kasala et al, 2021, Journal of Controlled Release CrossRef
12. Non-Human Primate-Derived Adenoviruses for Future Use as Oncolytic Agents?
    Selas T.F. Bots et al, 2020, International Journal of Molecular Sciences CrossRef